APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhalational Isoflurane

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inhalational Isoflurane Industry Growth and Trends Forecast to 2032

Report ID 174002880127 December 2025103 pages

Choose your research edition.

Industry ResearchInhalational Isoflurane Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalational Isoflurane Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Inhalational Isoflurane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalational Isoflurane Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalational Isoflurane Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Inhalational Isoflurane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inhalational Isoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inhalational Isoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalational Isoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalational Isoflurane include KALBE PHARMA, AbbVie, LAB UNKNOWN, Neon Laboratories, Piramal, PT Novell Pharmaceutical, Sedana Medical, Baxter and Viatris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inhalational Isoflurane market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhalational Isoflurane market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhalational Isoflurane market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhalational Isoflurane.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inhalational Isoflurane market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhalational Isoflurane Market by Company

KALBE PHARMA

AbbVie

LAB UNKNOWN

Neon Laboratories

Piramal

PT Novell Pharmaceutical

Sedana Medical

Baxter

Viatris

Lunan Beite

Inhalational Isoflurane Segment by Type

Brand Drug

Generic Drugs

Inhalational Isoflurane Segment by Application

Clinic

Hospital

Other

Inhalational Isoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalational Isoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalational Isoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalational Isoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalational Isoflurane manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inhalational Isoflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Brand Drug Table 2. Major Company of Generic Drugs Table 3. Global Inhalational Isoflurane Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Inhalational Isoflurane Sales by Type (2021-2026) & (K Units) Table 5. Global Inhalational Isoflurane Sales Market Share in Volume by Type (2021-2026) Table 6. Global Inhalational Isoflurane Sales by Type (2021-2026) & (US$ Million) Table 7. Global Inhalational Isoflurane Sales Market Share in Value by Type (2021-2026) Table 8. Global Inhalational Isoflurane Price by Type (2021-2026) & (US$/Unit) Table 9. Global Inhalational Isoflurane Sales by Type (2027-2032) & (K Units) Table 10. Global Inhalational Isoflurane Sales Market Share in Volume by Type (2027-2032) Table 11. Global Inhalational Isoflurane Sales by Type (2027-2032) & (US$ Million) Table 12. Global Inhalational Isoflurane Sales Market Share in Value by Type (2027-2032) Table 13. Global Inhalational Isoflurane Price by Type (2027-2032) & (US$/Unit) Table 14. North America Inhalational Isoflurane Sales by Type (2021-2026) & (K Units) Table 15. North America Inhalational Isoflurane Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Inhalational Isoflurane Sales by Type (2021-2026) & (K Units) Table 17. Europe Inhalational Isoflurane Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Inhalational Isoflurane Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Inhalational Isoflurane Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Inhalational Isoflurane Sales by Type (2021-2026) & (K Units) Table 21. Latin America Inhalational Isoflurane Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Inhalational Isoflurane Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Inhalational Isoflurane Sales by Type (2021-2026) & (US$ Million) Table 24. Inhalational Isoflurane Industry Trends Table 25. Inhalational Isoflurane Industry Drivers Table 26. Inhalational Isoflurane Industry Opportunities and Challenges Table 27. Inhalational Isoflurane Industry Restraints Table 28. Global Inhalational Isoflurane Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Inhalational Isoflurane Revenue Market Share by Company (2021-2026) Table 30. Global Inhalational Isoflurane Sales by Company (2021-2026) & (K Units) Table 31. Global Inhalational Isoflurane Sales Share by Company (2021-2026) Table 32. Global Inhalational Isoflurane Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Inhalational Isoflurane Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Inhalational Isoflurane Major Company Production Sites and Headquarters Table 35. Global Inhalational Isoflurane Company, Product Type & Application Table 36. Global Inhalational Isoflurane Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Inhalational Isoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Inhalational Isoflurane Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Inhalational Isoflurane Sales by Region (2021-2026) & (K Units) Table 41. Global Inhalational Isoflurane Sales Market Share in Volume by Region (2021-2026) Table 42. Global Inhalational Isoflurane Sales by Region (2021-2026) & (US$ Million) Table 43. Global Inhalational Isoflurane Sales Market Share in Value by Region (2021-2026) Table 44. Global Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Inhalational Isoflurane Sales by Region (2027-2032) & (K Units) Table 46. Global Inhalational Isoflurane Sales Market Share in Volume by Region (2027-2032) Table 47. Global Inhalational Isoflurane Sales by Region (2027-2032) & (US$ Million) Table 48. Global Inhalational Isoflurane Sales Market Share in Value by Region (2027-2032) Table 49. Global Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Inhalational Isoflurane Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Inhalational Isoflurane Sales by Application (2021-2026) & (K Units) Table 52. Global Inhalational Isoflurane Sales Market Share in Volume by Application (2021-2026) Table 53. Global Inhalational Isoflurane Sales by Application (2021-2026) & (US$ Million) Table 54. Global Inhalational Isoflurane Sales Market Share in Value by Application (2021-2026) Table 55. Global Inhalational Isoflurane Price by Application (2021-2026) & (US$/Unit) Table 56. Global Inhalational Isoflurane Sales by Application (2027-2032) & (K Units) Table 57. Global Inhalational Isoflurane Sales Market Share in Volume by Application (2027-2032) Table 58. Global Inhalational Isoflurane Sales by Application (2027-2032) & (US$ Million) Table 59. Global Inhalational Isoflurane Sales Market Share in Value by Application (2027-2032) Table 60. Global Inhalational Isoflurane Price by Application (2027-2032) & (US$/Unit) Table 61. North America Inhalational Isoflurane Sales by Application (2021-2026) & (K Units) Table 62. North America Inhalational Isoflurane Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Inhalational Isoflurane Sales by Application (2021-2026) & (K Units) Table 64. Europe Inhalational Isoflurane Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Inhalational Isoflurane Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Inhalational Isoflurane Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Inhalational Isoflurane Sales by Application (2021-2026) & (K Units) Table 68. Latin America Inhalational Isoflurane Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Inhalational Isoflurane Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Inhalational Isoflurane Sales by Application (2021-2026) & (US$ Million) Table 71. KALBE PHARMA Company Information Table 72. KALBE PHARMA Business Overview Table 73. KALBE PHARMA Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. KALBE PHARMA Inhalational Isoflurane Product Portfolio Table 75. KALBE PHARMA Recent Development Table 76. AbbVie Company Information Table 77. AbbVie Business Overview Table 78. AbbVie Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AbbVie Inhalational Isoflurane Product Portfolio Table 80. AbbVie Recent Development Table 81. LAB UNKNOWN Company Information Table 82. LAB UNKNOWN Business Overview Table 83. LAB UNKNOWN Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. LAB UNKNOWN Inhalational Isoflurane Product Portfolio Table 85. LAB UNKNOWN Recent Development Table 86. Neon Laboratories Company Information Table 87. Neon Laboratories Business Overview Table 88. Neon Laboratories Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Neon Laboratories Inhalational Isoflurane Product Portfolio Table 90. Neon Laboratories Recent Development Table 91. Piramal Company Information Table 92. Piramal Business Overview Table 93. Piramal Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Piramal Inhalational Isoflurane Product Portfolio Table 95. Piramal Recent Development Table 96. PT Novell Pharmaceutical Company Information Table 97. PT Novell Pharmaceutical Business Overview Table 98. PT Novell Pharmaceutical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolio Table 100. PT Novell Pharmaceutical Recent Development Table 101. Sedana Medical Company Information Table 102. Sedana Medical Business Overview Table 103. Sedana Medical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sedana Medical Inhalational Isoflurane Product Portfolio Table 105. Sedana Medical Recent Development Table 106. Baxter Company Information Table 107. Baxter Business Overview Table 108. Baxter Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Baxter Inhalational Isoflurane Product Portfolio Table 110. Baxter Recent Development Table 111. Viatris Company Information Table 112. Viatris Business Overview Table 113. Viatris Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Viatris Inhalational Isoflurane Product Portfolio Table 115. Viatris Recent Development Table 116. Lunan Beite Company Information Table 117. Lunan Beite Business Overview Table 118. Lunan Beite Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Lunan Beite Inhalational Isoflurane Product Portfolio Table 120. Lunan Beite Recent Development Table 121. North America Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Inhalational Isoflurane Sales by Country (2021-2026) & (K Units) Table 123. North America Inhalational Isoflurane Sales Market Share by Country (2021-2026) Table 124. North America Inhalational Isoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Inhalational Isoflurane Sales Market Share Forecast by Country (2027-2032) Table 126. North America Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Inhalational Isoflurane Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Inhalational Isoflurane Market Share by Country (2021-2026) Table 129. North America Inhalational Isoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Inhalational Isoflurane Market Share Forecast by Country (2027-2032) Table 131. Europe Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Inhalational Isoflurane Sales by Country (2021-2026) & (K Units) Table 133. Europe Inhalational Isoflurane Sales Market Share by Country (2021-2026) Table 134. Europe Inhalational Isoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Inhalational Isoflurane Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Inhalational Isoflurane Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Inhalational Isoflurane Market Share by Country (2021-2026) Table 139. Europe Inhalational Isoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Inhalational Isoflurane Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Inhalational Isoflurane Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Inhalational Isoflurane Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Inhalational Isoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Inhalational Isoflurane Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Inhalational Isoflurane Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Inhalational Isoflurane Market Share by Country (2021-2026) Table 149. Asia-Pacific Inhalational Isoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Inhalational Isoflurane Market Share Forecast by Country (2027-2032) Table 151. Latin America Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Inhalational Isoflurane Sales by Country (2021-2026) & (K Units) Table 153. Latin America Inhalational Isoflurane Sales Market Share by Country (2021-2026) Table 154. Latin America Inhalational Isoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Inhalational Isoflurane Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Inhalational Isoflurane Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Inhalational Isoflurane Market Share by Country (2021-2026) Table 159. Latin America Inhalational Isoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Inhalational Isoflurane Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Inhalational Isoflurane Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Inhalational Isoflurane Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Inhalational Isoflurane Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Inhalational Isoflurane Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Inhalational Isoflurane Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Inhalational Isoflurane Market Share by Country (2021-2026) Table 169. Middle East and Africa Inhalational Isoflurane Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Inhalational Isoflurane Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Inhalational Isoflurane Distributors List Table 174. Inhalational Isoflurane Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Inhalational Isoflurane Image Figure 2. Global Inhalational Isoflurane Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalational Isoflurane Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalational Isoflurane Sales (2021-2032) & (K Units) Figure 5. Brand Drug Image Figure 6. Global Brand Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drugs Image Figure 8. Global Generic Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Inhalational Isoflurane Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Inhalational Isoflurane Market Share by Type 2025 VS 2032 Figure 11. North America Inhalational Isoflurane Sales Market Share in Volume by Type in 2025 Figure 12. North America Inhalational Isoflurane Sales Market Share in Value by Type in 2025 Figure 13. Europe Inhalational Isoflurane Sales Market Share in Volume by Type in 2025 Figure 14. Europe Inhalational Isoflurane Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Inhalational Isoflurane Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Inhalational Isoflurane Sales Market Share in Value by Type in 2025 Figure 17. Latin America Inhalational Isoflurane Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Inhalational Isoflurane Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Inhalational Isoflurane Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Inhalational Isoflurane Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Inhalational Isoflurane Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Inhalational Isoflurane Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Inhalational Isoflurane Market Share by Application 2025 VS 2032 Figure 31. North America Inhalational Isoflurane Sales Market Share in Volume by Application in 2025 Figure 32. North America Inhalational Isoflurane Sales Market Share in Value by Application in 2025 Figure 33. Europe Inhalational Isoflurane Sales Market Share in Volume by Application in 2025 Figure 34. Europe Inhalational Isoflurane Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Inhalational Isoflurane Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Inhalational Isoflurane Sales Market Share in Value by Application in 2025 Figure 37. Latin America Inhalational Isoflurane Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Inhalational Isoflurane Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Inhalational Isoflurane Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Inhalational Isoflurane Sales Market Share in Value by Application in 2025 Figure 41. North America Inhalational Isoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Inhalational Isoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Inhalational Isoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Inhalational Isoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Inhalational Isoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Inhalational Isoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Inhalational Isoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Inhalational Isoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Inhalational Isoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Inhalational Isoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Inhalational Isoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Inhalational Isoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Inhalational Isoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Inhalational Isoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Inhalational Isoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Inhalational Isoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Inhalational Isoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Inhalational Isoflurane Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Inhalational Isoflurane Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Inhalational Isoflurane Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Inhalational Isoflurane Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Inhalational Isoflurane Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drugs
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • KALBE PHARMA
  • AbbVie
  • LAB UNKNOWN
  • Neon Laboratories
  • Piramal
  • PT Novell Pharmaceutical
  • Sedana Medical
  • Baxter
  • Viatris
  • Lunan Beite

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalational Isoflurane Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inhalational Isoflurane Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inhalational Isoflurane Market by Type
  6. 1.3.1 Brand Drug
  7. 1.3.2 Generic Drugs
  8. 1.4 Global Inhalational Isoflurane Market Size by Type
  9. 1.4.1 Global Inhalational Isoflurane Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Inhalational Isoflurane Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Inhalational Isoflurane Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Inhalational Isoflurane Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Inhalational Isoflurane Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Inhalational Isoflurane Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Inhalational Isoflurane Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Inhalational Isoflurane Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inhalational Isoflurane Industry Trends
  2. 2.2 Inhalational Isoflurane Industry Drivers
  3. 2.3 Inhalational Isoflurane Industry Opportunities and Challenges
  4. 2.4 Inhalational Isoflurane Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inhalational Isoflurane Revenue (2021-2026)
  2. 3.2 Global Top Players by Inhalational Isoflurane Sales (2021-2026)
  3. 3.3 Global Top Players by Inhalational Isoflurane Price (2021-2026)
  4. 3.4 Global Inhalational Isoflurane Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalational Isoflurane Major Company Production Sites & Headquarters
  6. 3.6 Global Inhalational Isoflurane Company, Product Type & Application
  7. 3.7 Global Inhalational Isoflurane Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalational Isoflurane Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalational Isoflurane Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalational Isoflurane Tier 1, Tier 2, and Tier 3
4 Inhalational Isoflurane Regional Status and Outlook
  1. 4.1 Global Inhalational Isoflurane Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inhalational Isoflurane Historic Market Size by Region
  3. 4.2.1 Global Inhalational Isoflurane Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inhalational Isoflurane Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inhalational Isoflurane Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inhalational Isoflurane Forecasted Market Size by Region
  7. 4.3.1 Global Inhalational Isoflurane Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inhalational Isoflurane Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inhalational Isoflurane Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhalational Isoflurane by Application
  1. 5.1 Inhalational Isoflurane Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Inhalational Isoflurane Market Size by Application
  6. 5.2.1 Global Inhalational Isoflurane Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Inhalational Isoflurane Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Inhalational Isoflurane Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Inhalational Isoflurane Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Inhalational Isoflurane Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Inhalational Isoflurane Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Inhalational Isoflurane Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Inhalational Isoflurane Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 KALBE PHARMA
  2. 6.1.1 KALBE PHARMA Company Information
  3. 6.1.2 KALBE PHARMA Business Overview
  4. 6.1.3 KALBE PHARMA Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 KALBE PHARMA Inhalational Isoflurane Product Portfolio
  6. 6.1.5 KALBE PHARMA Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Inhalational Isoflurane Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 LAB UNKNOWN
  14. 6.3.1 LAB UNKNOWN Company Information
  15. 6.3.2 LAB UNKNOWN Business Overview
  16. 6.3.3 LAB UNKNOWN Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 LAB UNKNOWN Inhalational Isoflurane Product Portfolio
  18. 6.3.5 LAB UNKNOWN Recent Developments
  19. 6.4 Neon Laboratories
  20. 6.4.1 Neon Laboratories Company Information
  21. 6.4.2 Neon Laboratories Business Overview
  22. 6.4.3 Neon Laboratories Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Neon Laboratories Inhalational Isoflurane Product Portfolio
  24. 6.4.5 Neon Laboratories Recent Developments
  25. 6.5 Piramal
  26. 6.5.1 Piramal Company Information
  27. 6.5.2 Piramal Business Overview
  28. 6.5.3 Piramal Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Piramal Inhalational Isoflurane Product Portfolio
  30. 6.5.5 Piramal Recent Developments
  31. 6.6 PT Novell Pharmaceutical
  32. 6.6.1 PT Novell Pharmaceutical Company Information
  33. 6.6.2 PT Novell Pharmaceutical Business Overview
  34. 6.6.3 PT Novell Pharmaceutical Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolio
  36. 6.6.5 PT Novell Pharmaceutical Recent Developments
  37. 6.7 Sedana Medical
  38. 6.7.1 Sedana Medical Company Information
  39. 6.7.2 Sedana Medical Business Overview
  40. 6.7.3 Sedana Medical Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sedana Medical Inhalational Isoflurane Product Portfolio
  42. 6.7.5 Sedana Medical Recent Developments
  43. 6.8 Baxter
  44. 6.8.1 Baxter Company Information
  45. 6.8.2 Baxter Business Overview
  46. 6.8.3 Baxter Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Baxter Inhalational Isoflurane Product Portfolio
  48. 6.8.5 Baxter Recent Developments
  49. 6.9 Viatris
  50. 6.9.1 Viatris Company Information
  51. 6.9.2 Viatris Business Overview
  52. 6.9.3 Viatris Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Viatris Inhalational Isoflurane Product Portfolio
  54. 6.9.5 Viatris Recent Developments
  55. 6.10 Lunan Beite
  56. 6.10.1 Lunan Beite Company Information
  57. 6.10.2 Lunan Beite Business Overview
  58. 6.10.3 Lunan Beite Inhalational Isoflurane Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lunan Beite Inhalational Isoflurane Product Portfolio
  60. 6.10.5 Lunan Beite Recent Developments
7 North America by Country
  1. 7.1 North America Inhalational Isoflurane Sales by Country
  2. 7.1.1 North America Inhalational Isoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inhalational Isoflurane Sales by Country (2021-2026)
  4. 7.1.3 North America Inhalational Isoflurane Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inhalational Isoflurane Market Size by Country
  6. 7.2.1 North America Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inhalational Isoflurane Market Size by Country (2021-2026)
  8. 7.2.3 North America Inhalational Isoflurane Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inhalational Isoflurane Sales by Country
  2. 8.1.1 Europe Inhalational Isoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inhalational Isoflurane Sales by Country (2021-2026)
  4. 8.1.3 Europe Inhalational Isoflurane Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inhalational Isoflurane Market Size by Country
  6. 8.2.1 Europe Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inhalational Isoflurane Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inhalational Isoflurane Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inhalational Isoflurane Sales by Country
  2. 9.1.1 Asia-Pacific Inhalational Isoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inhalational Isoflurane Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inhalational Isoflurane Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inhalational Isoflurane Market Size by Country
  6. 9.2.1 Asia-Pacific Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inhalational Isoflurane Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inhalational Isoflurane Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inhalational Isoflurane Sales by Country
  2. 10.1.1 South America Inhalational Isoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inhalational Isoflurane Sales by Country (2021-2026)
  4. 10.1.3 South America Inhalational Isoflurane Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inhalational Isoflurane Market Size by Country
  6. 10.2.1 South America Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inhalational Isoflurane Market Size by Country (2021-2026)
  8. 10.2.3 South America Inhalational Isoflurane Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inhalational Isoflurane Sales by Country
  2. 11.1.1 Middle East and Africa Inhalational Isoflurane Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inhalational Isoflurane Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inhalational Isoflurane Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inhalational Isoflurane Market Size by Country
  6. 11.2.1 Middle East and Africa Inhalational Isoflurane Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inhalational Isoflurane Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inhalational Isoflurane Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inhalational Isoflurane Value Chain Analysis
  2. 12.1.1 Inhalational Isoflurane Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inhalational Isoflurane Production Mode & Process
  7. 12.2 Inhalational Isoflurane Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inhalational Isoflurane Distributors
  10. 12.2.3 Inhalational Isoflurane Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst